Seregni E - Search Results

1

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari L, Bajetta E, Martinetti A, Celio L, Longarini R, La Torre I, Buzzoni R, Gattinoni L, Seregni E, Bombardieri E. Ferrari L, et al. Among authors: seregni e. Int J Oncol. 2003 May;22(5):1081-9. Int J Oncol. 2003. PMID: 12684675

2

The role of serum carcinoembryonic antigen (CEA) in the management of patients with colorectal carcinoma: the experience of the Istituto Tumori of Milan.

Seregni E, Bombardieri E, Bogni A, Crippa F, De Jager E, Buraggi GL. Seregni E, et al. Int J Biol Markers. 1992 Jul-Sep;7(3):167-70. doi: 10.1177/172460089200700308. Int J Biol Markers. 1992. PMID: 1431340

3

Pilot, multicenter and prospective trials with an anti-CEA antibody.

Buraggi GL, Gasparini M, Seregni E, Bombardieri E, Regalia E, Maffioli L. Buraggi GL, et al. Among authors: seregni e. Int J Biol Markers. 1992 Jul-Sep;7(3):189-92. doi: 10.1177/172460089200700312. Int J Biol Markers. 1992. PMID: 1431344 Clinical Trial.

4

CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases.

Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. Bombardieri E, et al. Among authors: seregni e. Eur J Cancer. 1992;29A(1):144-6. doi: 10.1016/0959-8049(93)90595-7. Eur J Cancer. 1992. PMID: 1445733

5

Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.

Crippa F, Bombardieri E, Seregni E, Castellani MR, Gasparini M, Maffioli L, Pizzichetta M, Buraggi GL. Crippa F, et al. Among authors: seregni e. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):52-5. J Nucl Biol Med (1991). 1992. PMID: 1450226

6

Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.

Boccardo F, Bombardieri E, Zanardi S, Valenti G, Zanaboni F, Valtolina M, Seregni E, Crippa F. Boccardo F, et al. Among authors: seregni e. Int J Biol Markers. 1991 Jan-Mar;6(1):12-20. doi: 10.1177/172460089100600103. Int J Biol Markers. 1991. PMID: 1856512

7

Mucinic tumor markers recognized by monoclonal antibodies.

Seregni E, Bombardieri E, Maffioli L, Buraggi GL. Seregni E, et al. J Nucl Med Allied Sci. 1990 Oct-Dec;34(4):314-20. J Nucl Med Allied Sci. 1990. PMID: 2090797 Review. No abstract available.

8

Radioimmunodetection of melanoma: preliminary results of a prospective study.

Buraggi G, Turrin A, Cascinelli N, Attili A, Gasparini M, Callegaro L, Ferrone S, Seregni E, Bombardieri E, Belli F. Buraggi G, et al. Among authors: seregni e. Int J Biol Markers. 1986 Jan-Apr;1(1):47-54. doi: 10.1177/172460088600100108. Int J Biol Markers. 1986. PMID: 2826619

9

Evaluation of cytokeratin 19 serum fragments (CYFRA 21-1) in patients with lung cancer: results of a multicenter trial.

Bombardieri E, Seregni E, Bogni A, Ardit S, Belloli S, Busetto A, Caniello B, Castelli M, Cianetti A, Correale M, et al. Bombardieri E, et al. Among authors: seregni e. Int J Biol Markers. 1994 Apr-Jun;9(2):89-95. doi: 10.1177/172460089400900205. Int J Biol Markers. 1994. PMID: 7523547 Clinical Trial.

10

Biochemical characteristics and clinical applications of alpha-fetoprotein isoforms.

Seregni E, Botti C, Bombardieri E. Seregni E, et al. Anticancer Res. 1995 Jul-Aug;15(4):1491-9. Anticancer Res. 1995. PMID: 7544570 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters